| | | |
Acute Lymphoblastic Leukemia |
NCT06137118 D7405C00001 | AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia | Dr. Andre Schuh | Acute Lymphoblastic Leukemia |
NCT04994717 20190360, 2023-503640-14 | Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia | Dr. Andre Schuh | Acute Lymphoblastic Leukemia |
Acute Myelogenous Leukemia |
NCT04811560 CR108998, 75276617ALE1001,2023-506581-31-00 | A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia | Dr. Andre Schuh | Acute Myelogenous Leukemia |
NCT06226571 SNDX-5613-0708, 2024-514531-18-00 | A Study of SNDX-5613 in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias | Dr. Andre Schuh | Acute Myelogenous Leukemia |
NCT05907057 DIM-95031-006, 2022-501709-11 | An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy. | Dr. Andre Schuh | Acute Myelogenous Leukemia |
Chronic Myeloid Leukemia |
NCT05304377 ELVN-001-101 | A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia | Dr. Dennis Kim | Chronic Myeloid Leukemia |
NCT06384261 OV-AML-1231 | A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy | Dr. Karen Yee | Chronic Myeloid Leukemia |
NCT06423911 HQP1351CG301 | Study of Olverembatinib (HQP1351) in Patients With CP-CML | Dr. Dennis Kim | Chronic Myeloid Leukemia |
Multiple Sites |
NCT04256317 ASTX030-01 | A Study of ASTX030 (Cedazuridine in Combination With Azacitidine) in MDS, CMML, or AML | Dr. Guillaume Richard-Carpentier | Multiple Sites |
NCT04730258 TWT-202 | A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMML | Dr. Karen Yee | Multiple Sites |
NCT06150157 88549968MPN1001, 88549968MPN1001,2023-505584-36-00 | A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms | Dr. Vikas Gupta | Multiple Sites |
NCT06618001 89853413AML1001, 89853413AML1001,2024-513199-16-00 | A Study of JNJ-89853413 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms | Dr. Guillaume Richard-Carpentier | Multiple Sites |
NCT04224974 SC26 | Emotion and Symptom-Focused Engagement Trial for Individuals With Acute Leukemia | Dr. Gary Rodin | Multiple Sites |
NCT03168815 vSep2016 | Low-Flow vs. High-Flow Nasal Cannula for Hypoxemic Immunocompromised Patients During Diagnostic Bronchoscopy | Dr. Lorenzo Del Sorbo | Multiple Sites |
NCT04279847 INCB 57643-103, 2023-506145-38-00,2020-003532-25 | Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms | Dr. Vikas Gupta | Multiple Sites |
NCT06419634 CA235-0001, 2024-519537-29 | Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome | Dr. Andre Schuh | Multiple Sites |
NCT04260022 HQP1351CU101 | Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL | Dr. Dennis Kim | Multiple Sites |
NCT03816319 NCI-2019-00238, NCI-2019-00238,10237,10237,UM1CA186644 | TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes With Increased Blasts | Dr. Guillaume Richard-Carpentier | Multiple Sites |
NCT05600894 NCI-2022-08797, NCI-2022-08797,10538,10538,UM1CA186689 | Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm | Dr. Marta Davidson | Multiple Sites |
Myelodysplastic Syndrome (MDS) |
NCT06499285 KER-050-D301 | The Efficacy and Safety of Elritercept in Adult Participants With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) With Anemia (RENEW) | Dr. Karen Yee | Myelodysplastic Syndrome (MDS) |